Key result
PCI linked to ~74% lower death or MI risk versus medical therapy in collateralized CTO.
Why the study?
The impact of PCI on chronic total occlusion in patients with well-developed collaterals was not clear.
Does percutaneous coronary intervention reduce death or myocardial infarction compared to optimal medical therapy in patients with chronic total coronary occlusion and well-developed collaterals?
Cohort (n=640)
Does percutaneous coronary intervention reduce death or myocardial infarction compared to optimal medical therapy in patients with chronic total coronary occlusion and well-developed collaterals?
In patients with chronic total occlusions and well-developed collaterals, successful PCI may reduce the risk of death or myocardial infarction and improve left ventricular function compared to medical therapy alone, despite an increased need for repeat revascularization.
Answers are grounded in this paper and cite their sources.
May support PCI consideration in CTO with collaterals; leaves open need for randomized confirmation of benefit.
Background The impact of percutaneous coronary intervention ( PCI ) on chronic total occlusion in patients with well‐developed collaterals is not clear. Methods and Results A total of 640 chronic total occlusion patients with collateral flow grade ≥2 were divided into 2 groups; chronic total occlusion patients either treated with PCI (the PCI group; n=305) or optimal medical therapy (the optimal medical therapy group; n=335). To adjust for potential confounders, a propensity score matching analysis was performed. Major clinical outcomes were compared between the 2 groups up to 5 years. In the entire population, the PCI group had a lower hazard of myocardial infarction (hazard ratio [ HR ], 0.177; P =0.039; 95% confidence interval [ CI ], 0.03–0.91) and the composite of total death or myocardial infarction ( HR , 0.298; P =0.017; 95% CI , 0.11–0.80); however, it showed higher hazard of target lesion revascularization ( HR , 3.942; P =0.003; 95% CI , 1.58–9.81) and target vessel revascularization ( HR , 4.218; P =0.001; 95% CI , 1.85–9.60). After propensity score matching, a total of 158 matched pairs were generated. Although the PCI group showed a higher hazard of target lesion revascularization ( HR , 2.868; P =0.027; 95% CI , 1.13–7.31) and target vessel revascularization ( HR =2.62; P =0.022; 95% CI , 1.15–5.97), it still exhibited a lower incidence of the composite of total death or myocardial infarction ( HR , 0.263; P =0.017; 95% CI , 0.087–0.790). The mean ejection fraction was improved from 47.8% to 51.6% ( P <0.001) after PCI . Conclusions In our study, successful revascularization by PCI for chronic total occlusion lesions with well‐developed collaterals was associated with lower incidence of death and myocardial infarction, improved left ventricular function, but increased repeat revascularization rate.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2017) conducted a cohort in Chronic total coronary occlusion with well-developed collaterals (n=640). Percutaneous coronary intervention (PCI) vs. Optimal medical therapy was evaluated on Composite of total death or myocardial infarction (HR 0.263, 95% CI 0.087-0.790, p=0.017). In patients with chronic total occlusion and well-developed collaterals, PCI was associated with a lower incidence of death or myocardial infarction compared to medical therapy (HR 0.263; 95% CI 0.087-0.790).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: